NutriBand (NTRB) Free Cash Flow Growth (3y) (2019 - 2026)
NutriBand (NTRB) Free Cash Flow Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
NutriBand |
41.21 Mn |
36.63 Mn |
88,941.00 |
3.88% |
| Date | Value |
|---|
| Jan 31, 2026 |
3.88% |
| Oct 31, 2025 |
-49.76% |
| Jul 31, 2025 |
-12.08% |
| Apr 30, 2025 |
-19.43% |
| Jan 31, 2025 |
0.62% |
| Oct 31, 2024 |
4.44% |
| Jul 31, 2024 |
-151.79% |
| Apr 30, 2024 |
-38.21% |
| Jan 31, 2024 |
-109.76% |
| Oct 31, 2023 |
-133.13% |
| Jul 31, 2023 |
-107.03% |
| Apr 30, 2023 |
-55.14% |
| Jan 31, 2023 |
-91.39% |
| Oct 31, 2022 |
-25.12% |
| Jul 31, 2022 |
-57.66% |
| Apr 30, 2022 |
-42.46% |
| Jan 31, 2022 |
-64.65% |
| Oct 31, 2021 |
-40.17% |
| Jul 31, 2021 |
34.67% |
| Apr 30, 2021 |
-126.34% |
